Houston sees growth in coworking space, rises in national ranks for 2023

growing and flexing

Houston's coworking space is growing. Photo courtesy of The Cannon

Houston continues to grow its coworking space across the city — and the progress is notable just between the first and second quarters of 2023, a recent report shows.

When it comes to coworking space growth, Houston saw an increase of 16 percent between June and March of 2023, reports CoworkingCafe. This stat means Houston outpaced the national average, which is 10 percent. Houston, which now has a reported 208 coworking and flex office space facilities, edged out Boston in the overall rankings of cities based on number of coworking spaces.

Houston ranks No. 7 now behind Manhattan, Los Angeles, Washington, D.C., Chicago, Dallas - Fort Worth, and Atlanta, respectively.

When it came to the amount of space coworkers in Houston have, the Bayou City reported "an equally impressive expansion in terms of square footage," reads the report, "the market logged the highest increase in this metric and ended at more than 4,160,000 square feet of coworking space."

Nationally, coworking space totals 120 million square feet, which is a 6 percent increase between Q1 and Q2 and about 1.74 percent of the total office space nationwide.

While Houston saw growth in its coworking space, half of the top 25 markets for coworking have seen decreases in 2023 so far. Philadelphia, Seattle, the Bay Area, and Denver saw a decreased square footage average, but this trend isn't reflected when it comes to the number of coworking spots, which "likely equates to an increased focus on smaller coworking spaces across the nation," the report finds.

"With falling property values in some cities and rising interest rates, the commercial real estate industry is at a crossroads," says Doug Ressler, business intelligence manager at Yardi Matrix, in the report. "Many companies still aren't certain the number of employees who will be in their physical office space in the near or long term. That has led to firms doing smaller projects with startups, like pilot tests, instead of larger-scale purchases."

In January, Texas coworking company Common Desk announced its sixth Houston-area location. Common Desk also shared that it's expanding in the Ion last December, and that construction is ongoing.

The Cannon, a Houston-based coworking company, its latest locations in Fish Creek and The Woodlands, which is a partnership with Amegy Bank.

From Your Site Articles
Both the city and state appear on a new report on best places for coworking. Photo via Getty Images

Report: Houston, Texas rank as top locations for coworking space

where to work

Attention all Houston-based remote workers, small business owners, and startups — if you're looking for flexible office space, you're in the right place.

Both the city and state have landed on CoworkingCafe's list of the best places for coworking in the country. With 652 reported coworking spots, Texas ranks as the No. 2 state — behind California 1,188 coworking spots and ahead of Florida's 629 and New York's 589 offices.

Houston ranks as eighth best metro for coworking with 208 coworking facilities. The Dallas-Fort Worth area ranked a few spots ahead of the Bayou City, coming in at No. 5 with 261 coworking spots. Austin also makes the top 2 with a reported 97 coworking spots, earning the No. 19 spot.

Data via coworkingcafe.com

According to the report, the area looked into included 15 cities within the Houston metro. The majority of the coworking properties —154 of the 208 identified — are located in Houston proper. Sugar Land has over 10 coworking spots, with the rest of the properties scattered across the greater Houston area in Katy, Spring, The Woodlands, etc.

Houston has followed the overall trend of increased remote workers, though not to the extreme other cities and states are seeing, according to the study. Per a Statista report, the number of people working in coworking spaces today has more than tripled since 2015. Houston's remote workers increased to 16 percent in 2021 from 4 percent in 2019.

"Even though Houston is already an established working hub with great job opportunities, it is also one of the cities with the lowest change in the share of remote workers," the report reads. "The change, however, still accounts for a notable outcome."

Earlier this year, a Seattle-based human resources company named Karat conducted their own report on the most attractive metros for remote workers within tech. In that 2022 study, Houston ranked No. 6 just ahead of No. 7 Austin. Last year, Houston ranked as No. 2 and Dallas at No. 9, but that North Texas metro fell off the top 10 for 2021. Pittsburgh maintained its top spot on this list year over year.

"Last year we took our first look at the rapidly expanding remote software engineer hiring landscape. As more organizations shifted to remote or hybrid working models we had started to see significantly improving candidate performance outside of the more-established tech hubs," writes Patrick Wu, data analyst at Karat, in a blog post. "Today, as even more top tech companies commit to hiring remote software engineers, we’re taking a look at how this landscape has continued to evolve."

The full ranking of CoworkingCafe's report is below.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

3 Houston startups named most innovative in Texas by LexisNexis

report card

Three Houston companies claimed spots on LexisNexis's 10 Most Innovative Startups in Texas report, with two working in the geothermal energy space.

Sage Geosystems claimed the No. 3 spot on the list, and Fervo Energy followed closely behind at No. 5. Fintech unicorn HighRadius rounded out the list of Houston companies at No. 8.

LexisNexis Intellectual Property Solutions compiled the report. It was based on each company's Patent Asset Index, a proprietary metric from LexisNexis that identifies the strength and value of each company’s patent assets based on factors such as patent quality, geographic scope and size of the portfolio.

Houston tied with Austin, each with three companies represented on the list. Caris Life Sciences, a biotechnology company based in Dallas, claimed the top spot with a Patent Asset Index more than 5 times that of its next competitor, Apptronik, an Austin-based AI-powered humanoid robotics company.

“Texas has always been fertile ground for bold entrepreneurs, and these innovative startups carry that tradition forward with strong businesses based on outstanding patent assets,” Marco Richter, senior director of IP analytics and strategy for LexisNexis Intellectual Property Solutions, said in a release. “These companies have proven their innovation by creating the most valuable patent portfolios in a state that’s known for game-changing inventions and cutting-edge technologies.We are pleased to recognize Texas’ most innovative startups for turning their ideas into patented innovations and look forward to watching them scale, disrupt, and thrive on the foundation they’ve laid today.”

This year's list reflects a range in location and industry. Here's the full list of LexisNexis' 10 Most Innovative Startups in Texas, ranked by patent portfolios.

  1. Caris (Dallas)
  2. Apptronik (Austin)
  3. Sage Geosystems (Houston)
  4. HiddenLayer (Austin)
  5. Fervo Energy (Houston)
  6. Plus One Robotics (San Antonio)
  7. Diligent Robotics (Austin)
  8. HighRadius (Houston)
  9. LTK (Dallas)
  10. Eagle Eye Networks (Austin)

Sage Geosystems has partnered on major geothermal projects with the United States Department of Defense's Defense Innovation Unit, the U.S. Air Force and Meta Platforms. Sage's 3-megawatt commercial EarthStore geothermal energy storage facility in Christine, Texas, was expected to be completed by the end of last year.

Fervo Energy fully contracted its flagship 500 MW geothermal development, Cape Station, this spring. Cape Station is currently one of the world’s largest enhanced geothermal systems (EGS) developments, and the station will begin to deliver electricity to the grid in 2026. The company was recently named North American Company of the Year by research and consulting firm Cleantech Group and came in at No. 6 on Time magazine and Statista’s list of America’s Top GreenTech Companies of 2025. It's now considered a unicorn, meaning its valuation as a private company has surpassed $1 billion.

Meanwhile, HighRadius announced earlier this year that it plans to release a fully autonomous finance platform for the "office of the CFO" by 2027. The company reached unicorn status in 2020.

---

This article originally appeared on Energy Capital HTX.

UH student earns prestigious award for cancer vaccine research

up-and-comer

Cole Woody, a biology major in the College of Natural Sciences and Mathematics at the University of Houston, has been awarded a Barry Goldwater Scholarship, becoming the first sophomore in UH history to earn the prestigious prize for research in natural sciences, mathematics and engineering.

Woody was recognized for his research on developing potential cancer vaccines through chimeric RNAs. The work specifically investigates how a vaccine can more aggressively target cancers.

Woody developed the MHCole Pipeline, a bioinformatic tool that predicts peptide-HLA binding affinities with nearly 100 percent improvement in data processing efficiency. The MHCole Pipeline aims to find cancer-specific targets and develop personalized vaccines. Woody is also a junior research associate at the UH Sequencing Core and works in Dr. Steven Hsesheng Lin’s lab at MD Anderson Cancer Center.

“Cole’s work ethic and dedication are unmatched,” Preethi Gunaratne, director of the UH Sequencing Core and professor of Biology & Biochemistry at NSM, said in a news release. “He consistently worked 60 to 70 hours a week, committing himself to learning new techniques and coding the MHCole pipeline.”

Woody plans to earn his MD-PhD and has been accepted into the Harvard/MIT MD-PhD Early Access to Research Training (HEART) program. According to UH, recipients of the Goldwater Scholarship often go on to win various nationally prestigious awards.

"Cole’s ability to independently design and implement such a transformative tool at such an early stage in his career demonstrates his exceptional technical acumen and creative problem-solving skills, which should go a long way towards a promising career in immuno-oncology,” Gunaratne added in the release.

Houston founder on shaping the future of medicine through biotechnology and resilience

Guest Column

Living with chronic disease has shaped my life in profound ways. My journey began in 5th grade when I was diagnosed with Scheuermann’s disease, a degenerative disc condition that kept me sidelined for an entire year. Later, I was diagnosed with hereditary neuropathy with liability to pressure palsies (HNPP), a condition that significantly impacts nerve recovery. These experiences didn’t just challenge me physically, they reshaped my perspective on healthcare — and ultimately set me on my path to entrepreneurship. What started as personal health struggles evolved into a mission to transform patient care through innovative biotechnology.

A defining part of living with these conditions was the diagnostic process. I underwent nerve tests that involved electrical shocks to my hands and arms — without anesthesia — to measure nerve activity. The pain was intense, and each test left me thinking: There has to be a better way. Even in those difficult moments, I found myself thinking about how to improve the tools and processes used in healthcare.

HNPP, in particular, has been a frustrating condition. For most people, sleeping on an arm might cause temporary numbness that disappears in an hour. For me, that same numbness can last six months. Even more debilitating is the loss of strength and fine motor skills. Living with this reality forced me to take an active role in understanding my health and seeking solutions, a mindset that would later shape my approach to leadership.

Growing up in Houston, I was surrounded by innovation. My grandfather, a pioneering urologist, was among the first to introduce kidney dialysis in the city in the 1950s. His dedication to advancing patient care initially inspired me to pursue medicine. Though my path eventually led me to healthcare administration and eventually biotech, his influence instilled in me a lifelong commitment to medicine and making a difference.

Houston’s thriving medical and entrepreneurial ecosystems played a critical role in my journey. The city’s culture of innovation and collaboration provided opportunities to explore solutions to unmet medical needs. When I transitioned from healthcare administration to founding biotech companies, I drew on the same resilience I had developed while managing my own health challenges.

My experience with chronic disease also shaped my leadership philosophy. Rather than accepting diagnoses passively, I took a proactive approach questioning assumptions, collaborating with experts, and seeking new solutions. These same principles now guide decision-making at FibroBiologics, where we are committed to developing groundbreaking therapies that go beyond symptom management to address the root causes of disease.

The resilience I built through my health struggles has been invaluable in navigating business challenges. While my early career in healthcare administration provided industry insights, launching and leading companies required the same determination I had relied on in my personal health journey.

I believe the future of healthcare lies in curative treatments, not just symptom management. Fibroblast cells hold the promise of engaging the body’s own healing processes — the most powerful cure for chronic diseases. Cell therapy represents both a scientific breakthrough and a significant business opportunity, one that has the potential to improve patient outcomes while reducing long-term healthcare costs.

Innovation in medicine isn’t just about technology; it’s about reimagining what’s possible. The future of healthcare is being written today. At FibroBiologics, our mission is driven by more than just financial success. We are focused on making a meaningful impact on patients’ lives, and this purpose-driven approach helps attract talent, engage stakeholders, and differentiate in the marketplace. Aligning business goals with patient needs isn’t just the right thing to do, it’s a powerful model for sustainable growth and lasting innovation in biotech.

---

Pete O’Heeron is the CEO and founder of FibroBiologics, a Houston-based regenerative medicine company.


View All Listings